HK1204005A1 - Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger rna rna - Google Patents

Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger rna rna

Info

Publication number
HK1204005A1
HK1204005A1 HK15104577.6A HK15104577A HK1204005A1 HK 1204005 A1 HK1204005 A1 HK 1204005A1 HK 15104577 A HK15104577 A HK 15104577A HK 1204005 A1 HK1204005 A1 HK 1204005A1
Authority
HK
Hong Kong
Prior art keywords
rna
feeder
human
stem cells
pluripotent stem
Prior art date
Application number
HK15104577.6A
Other languages
English (en)
Chinese (zh)
Inventor
王繼武
魯吉‧瓦蘭
倪毓輝
Original Assignee
Allele Biotechnology & Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allele Biotechnology & Pharmaceuticals Inc filed Critical Allele Biotechnology & Pharmaceuticals Inc
Publication of HK1204005A1 publication Critical patent/HK1204005A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0696Artificially induced pluripotent stem cells, e.g. iPS
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111General methods applicable to biologically active non-coding nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/14Type of nucleic acid interfering N.A.
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00Applications; Uses
    • C12N2320/30Special therapeutic applications
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60Transcription factors
    • C12N2501/602Sox-2
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60Transcription factors
    • C12N2501/603Oct-3/4
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60Transcription factors
    • C12N2501/605Nanog
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60Transcription factors
    • C12N2501/606Transcription factors c-Myc
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60Transcription factors
    • C12N2501/608Lin28
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/13Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
    • C12N2506/1307Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from adult fibroblasts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Transplantation (AREA)
  • Developmental Biology & Embryology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK15104577.6A 2012-05-13 2015-05-14 Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger rna rna HK1204005A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261646292P 2012-05-13 2012-05-13
PCT/US2013/040814 WO2013173248A2 (en) 2012-05-13 2013-05-13 Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger rna

Publications (1)

Publication Number Publication Date
HK1204005A1 true HK1204005A1 (en) 2015-11-06

Family

ID=49548771

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15104577.6A HK1204005A1 (en) 2012-05-13 2015-05-14 Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger rna rna

Country Status (10)

Country Link
EP (2) EP2850179B1 (xx)
JP (2) JP6448531B2 (xx)
KR (2) KR102081811B1 (xx)
CN (2) CN110241087B (xx)
AU (2) AU2013263101B2 (xx)
CA (1) CA2872688C (xx)
DK (1) DK2850179T3 (xx)
ES (2) ES2951822T3 (xx)
HK (1) HK1204005A1 (xx)
WO (1) WO2013173248A2 (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2788033B1 (en) 2011-12-05 2017-05-31 Factor Bioscience Inc. Methods and products for transfecting cells
JP6448531B2 (ja) * 2012-05-13 2019-01-09 アリール バイオテクノロジー アンド ファーマシューティカルズ, インコーポレイテッド 合成メッセンジャーrnaを使用したヒト人工多能性幹細胞のフィーダーフリー誘導
US10119150B2 (en) 2012-05-13 2018-11-06 Allele Biotechnology & Pharmaceuticals, Inc. Feeder-free Derivation of human-induced pluripotent stem cells with synthetic messenger RNA
US10155929B2 (en) * 2012-05-13 2018-12-18 Allele Biotechnology & Pharmaceuticals, Inc. Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger RNA
RU2019143431A (ru) 2012-11-01 2020-04-28 Фэктор Байосайенс Инк. Способы и продукты для экспрессии белков в клетках
MX2016009771A (es) 2014-01-31 2016-11-14 Factor Bioscience Inc Metodos y productos para la produccion y administracion de acido nucleico.
EP3543339A1 (en) 2015-02-13 2019-09-25 Factor Bioscience Inc. Nucleic acid products and methods of administration thereof
CA3011692A1 (en) * 2015-11-23 2017-06-01 The Regents Of The University Of Colorado, A Body Corporate Methods and compositions for reprogramming cells
CN116115629A (zh) 2016-08-17 2023-05-16 菲克特生物科学股份有限公司 核酸产品及其施用方法
CN109983118B (zh) * 2016-11-16 2024-04-16 美国绿阳生物技术及医药公司 以rna通过干细胞分化诱导肝细胞
IL266478B1 (en) * 2016-11-16 2024-10-01 Allele Biotechnology & Pharmaceuticals Inc Induction of pancreatic beta cells through stem cell differentiation with RNA
KR102122336B1 (ko) * 2018-10-26 2020-06-12 서울시립대학교 산학협력단 세포전환용 rna 나노입자를 이용한 유도만능줄기세포의 제조방법
US10501404B1 (en) 2019-07-30 2019-12-10 Factor Bioscience Inc. Cationic lipids and transfection methods
US20230053060A1 (en) * 2020-01-24 2023-02-16 I Peace, Inc. Method for manufacturing induced pluripotent stem cells

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260432A (en) * 1989-06-22 1993-11-09 Sloan-Kettering Institute For Cancer Research Human gamma retinoic acid receptor DNA
CA3060170A1 (en) * 2008-06-13 2009-12-17 Whitehead Institute For Biomedical Research Programming and reprogramming of cells
EP2192174B1 (en) * 2008-11-21 2015-11-11 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Reprogramming cells toward a pluripotent state
CN102597221B (zh) * 2009-11-04 2015-03-11 细胞动力国际有限公司 使用化学品的游离重编程
DK3287525T3 (da) * 2009-12-07 2020-01-20 Univ Pennsylvania RNA-præparater omfattende oprenset modificeret RNA til omprogrammering af celler
CN102190731B (zh) * 2010-03-09 2016-01-27 中国科学院上海生命科学研究院 用人工转录因子诱导产生多能干细胞
US9580689B2 (en) * 2010-07-22 2017-02-28 Regents Of The University Of Minnesota Induced pluripotent stem cells
WO2012012798A2 (en) * 2010-07-23 2012-01-26 University Of South Florida Materials and methods for reduction of protein tau and treatment of neurodegenerative diseases
CN102417894B (zh) * 2011-10-21 2013-06-05 中国科学院广州生物医药与健康研究院 一种提高诱导生成多能性干细胞效率的方法
US10155929B2 (en) * 2012-05-13 2018-12-18 Allele Biotechnology & Pharmaceuticals, Inc. Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger RNA
JP6448531B2 (ja) * 2012-05-13 2019-01-09 アリール バイオテクノロジー アンド ファーマシューティカルズ, インコーポレイテッド 合成メッセンジャーrnaを使用したヒト人工多能性幹細胞のフィーダーフリー誘導
CN103739718B (zh) * 2014-01-16 2017-02-08 中国科学院动物研究所 用于诱导多能干细胞的融合蛋白及其使用方法

Also Published As

Publication number Publication date
CN104520424A (zh) 2015-04-15
JP2015517311A (ja) 2015-06-22
KR20150035594A (ko) 2015-04-06
DK2850179T3 (da) 2019-06-17
JP6530452B2 (ja) 2019-06-12
JP2017184766A (ja) 2017-10-12
KR102215413B1 (ko) 2021-02-16
ES2951822T3 (es) 2023-10-25
CN110241087B (zh) 2023-02-03
KR102081811B1 (ko) 2020-02-26
WO2013173248A3 (en) 2014-12-18
AU2013263101A1 (en) 2014-11-27
EP2850179A4 (en) 2016-02-24
KR20200021553A (ko) 2020-02-28
CA2872688C (en) 2023-09-19
ES2729563T3 (es) 2019-11-04
CA2872688A1 (en) 2013-11-21
AU2013263101B2 (en) 2019-02-14
EP2850179A2 (en) 2015-03-25
EP3561054C0 (en) 2023-07-05
CN110241087A (zh) 2019-09-17
WO2013173248A2 (en) 2013-11-21
EP3561054A1 (en) 2019-10-30
EP2850179B1 (en) 2019-03-20
AU2019203335A1 (en) 2019-05-30
AU2019203335B2 (en) 2021-10-21
CN104520424B (zh) 2019-06-28
EP3561054B1 (en) 2023-07-05
JP6448531B2 (ja) 2019-01-09

Similar Documents

Publication Publication Date Title
HK1224335A1 (zh) 使用合成信使 無飼養層衍生人誘導多能幹細胞
HK1204005A1 (en) Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger rna rna
HK1199905A1 (en) Culturing of mesenchymal stem cells
EP2861612A4 (en) METHODS FOR PREPARING PLURIPOTENT STEM CELLS
SG11201503045YA (en) Methods of differentiating stem cells into one or more cell lineages
IL237898A0 (en) Systems for cell culture in 3D, and methods for their preparation and uses
EP2904103A4 (en) PROCESS FOR THE PREPARATION OF INDUCED PLURIPOTENT STEM CELLS AND APPLICATIONS THEREOF
EP2968549A4 (en) CELL CULTURE METHODS
EP2971040A4 (en) CELL CULTURE METHODS
EP3060650A4 (en) Culturing pluripotent stem cells
EP2971014A4 (en) CELL CULTURE METHODS
IL235132A0 (en) Differentiation of human embryonic stem cells into cardiac endodermis
EP2900808A4 (en) METHOD FOR DIFFERENTIATING STEM CELLS IN CHONDROCYTES
SG11201503167XA (en) Method of efficiently establishing induced pluripotent stem cells
EP2912166A4 (en) METHOD FOR THE PRODUCTION OF PLURIPOTENTIAL STEM CELLS FROM CHONDROCYTES
EP2913396A4 (en) METHOD FOR PRODUCING DIFFERENTIATED PLURIPOTENTER STEM CELLS
HK1222886A1 (zh) 哺乳動物肌源性幹細胞
GB201214704D0 (en) Stem cell culture method
EP2845862A4 (en) PROCESS FOR INCUBATING PLURIPOTENTER STEM CELLS AND POLYPEPTIDES FOR THE USE THEREOF
ZA201504388B (en) Method for culturing pluripotent stem cells
SG11201500139SA (en) Derivation and self-renewal of isi1+ cells and uses thereof
EP3008174A4 (en) Method of efficiently establishing induced pluripotent stem cells
EP3045451A4 (en) Compound promoting differentiation of pluripotent stem cells into cardiomyocytes
SG11201406771PA (en) Stem cell preparations and methods of use
IL249193B (en) Derivation of human pluripotential stem cells with nutrient-free synthetic messenger RNA